Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K RUdolf

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Molecular Pharmacology|August 1, 1996
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptorM Sautel, K Rudolf, H Wittneben, et al.
European Journal of Pharmacology|December 27, 1994
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226K Rudolf, W Eberlein, W Engel, et al.
Life Sciences|January 1, 1993
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacologyH N Doods, R Quirion, G Mihm, et al.
Human Reproduction (Oxford, England)|September 2, 1999
The outcome of intracytoplasmic sperm injection in patients with retrograde ejaculationN Nikolettos, S Al-Hasani, V Baukloh, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 26, 2005
PYY3-36 as an anti-obesity drug targetM M Boggiano, P C Chandler, K D Oswald, et al.
Nature|July 13, 2004
Physiology: does gut hormone PYY3-36 decrease food intake in rodents?M Tschöp, T R Castañeda, H G Joost, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Molecular Pharmacology|August 1, 1996
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptorM Sautel, K Rudolf, H Wittneben, et al.
European Journal of Pharmacology|December 27, 1994
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226K Rudolf, W Eberlein, W Engel, et al.
Life Sciences|January 1, 1993
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacologyH N Doods, R Quirion, G Mihm, et al.
Human Reproduction (Oxford, England)|September 2, 1999
The outcome of intracytoplasmic sperm injection in patients with retrograde ejaculationN Nikolettos, S Al-Hasani, V Baukloh, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 26, 2005
PYY3-36 as an anti-obesity drug targetM M Boggiano, P C Chandler, K D Oswald, et al.
Nature|July 13, 2004
Physiology: does gut hormone PYY3-36 decrease food intake in rodents?M Tschöp, T R Castañeda, H G Joost, et al.
Pageof 9